Gastric Neuroendocrine Tumors Drug Pipeline Analysis Report 2024
Studies suggest that gastric neuroendocrine tumors (G-NETs) are rare tumors, accounting for approximately 8% of all neuroendocrine tumors and affecting approximately 4 in 100,000 people. These tumors form in the lining of the gastrointestinal tract and primarily affect individuals aged 55 to 65. Sev